MAGLi 432

N/A

Report date: 2022/08/12 14:21:13
NME

Base Information

Drug NameMAGLi 432
Drug Alias NameMAGLi-432MAGLi 432
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoglyceride lipase inhibitors
TargetsMonoglyceride lipase
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRoche (China) Holding Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche (China) Holding Ltd
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A